Where does Ascensia Diabetes Care Holdings AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ascensia Diabetes Care Holdings AG ranks #1,788 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ascensia Diabetes Care Holdings AG hold?

Ascensia Diabetes Care Holdings AG holds 227 US utility patents granted between 2016 and 2025, spanning 49 technology areas.

What is Ascensia Diabetes Care Holdings AG's Innovation Score?

Ascensia Diabetes Care Holdings AG has an Innovation Score of 59.2 out of 100 (top 4% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Ascensia Diabetes Care Holdings AG's patent grant rate increasing or decreasing?

Ascensia Diabetes Care Holdings AG's recent grant velocity is -20% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Ascensia Diabetes Care Holdings AG's patents?

Ascensia Diabetes Care Holdings AG's patents average 19.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ascensia Diabetes Care Holdings AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ascensia Diabetes Care Holdings AG

Q: What technology areas does Ascensia Diabetes Care Holdings AG focus on?

Ascensia Diabetes Care Holdings AG's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 141 patents, ranking #92 of 7,863 assignees active in that subclass. Grants appear in 49 CPC subclasses total.

USPTO PatentsView assignee record - 227 granted patents across 49 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ascensia ranks #1,788 of 49,997 tracked US assignees by granted-patent volume, with 227 patents across 49 technology areas.

#1,788
of 49,997 US assignees by volume: Top 4%
by Innovation Score (59.2/100): 19.0
avg claims per patent: -20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1788 · Foreign Corporation #1,788 · 227 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 227 grants
TOP-DECILE #1,788/49,997
PHOTO-FINISH Axon Enterprise
CPC-WIDE G01N · 49 areas
INNOV-PAR 59.2/100
CLAIMS-RICH 19.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -20% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Axon Enterprise, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ascensia’s 59.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 18.8 pts (32%) Velocity 4.3 pts (7%) Breadth 24.7 pts (42%) Claim depth 11.4 pts (19%)

Qualcomm Incorporated · highest

85
Rohm and Haas · near

59
Ascensia Diabetes… · this assignee

59
Gigaphoton · near

59
Lubrizol Advanced… · near

59
VMI Holland B V · near

59
3D Lighting… · lowest

7

What this shows Ascensia's Innovation Score is 59.2/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ascensia?

Each dot is one of Ascensia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ascensia’s own 19.0 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ascensia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ascensia's grants concentrate

Ascensia Diabetes Care Holdings AG is a focused PatentsView assignee: 49 CPC subclasses with 62.1% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2019 (36 grants) versus a trough of 13 in 2024. By volume, Ascensia sits between tesa SE and Exedy Corporation.

Ascensia's three-year grant acceleration

From 2019–2021 to 2022–2024, Ascensia Diabetes Care Holdings AG moved from 81 to 52 grants (0.64x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,330. See the growth leaderboard.

tesa SE

229
Battelle Energy A…

228
Micro Motion

228
Tachi-s

228
Axon Enterprise

227
Bmic

227
Business Objects…

227
Exedy

227
Ascensia Diabetes… ◀

227

What this shows Ascensia holds 227 patents at rank #1,788, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ascensia

By rank, the assignees closest to #1,788 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Ascensia's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ascensia, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Ascensia ranks #92 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (59 here).

Gigaphoton Inc. 59 Lubrizol Advanced Materials, Inc. 59 VMI Holland B.V. 59 Rohm and Haas Company 59

Similar claim depth

Nearest assignees by average claims per patent (19.0 here).

MicroStrategy Incorporated 19.0 avg Atlassian US, Inc. 19.0 avg 8x8, Inc. 19.0 avg Epizyme, Inc. 19.0 avg

Ascensia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

59 Top 4% higher than 96% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Ascensia Diabetes Care Holdings AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	27	11.9%
2017	33	14.5%
2018	25	11.0%
2019	36	15.9%
2020	26	11.5%
2021	19	8.4%
2022	17	7.5%
2023	22	9.7%
2024	13	5.7%
2025partial year	9	4.0%

Which technologies does Ascensia Diabetes Care Holdings AG patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 141

A61B - DIAGNOSIS; SURGERY; Identification 129

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 57

Y10T - Technical Subjects Covered BY Former US Classification 32

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 31

G06F - Electric Digital Data Processing 23

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 15

G01K - Measuring TEMPERATURE; Measuring Quantity OF HEAT; Thermally-sensitive Elements NOT Otherwise Provided FOR 10

H04M - Telephonic Communication 9

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 9

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 8

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 8

H04W - Wireless Communication Networks 7

Y02D - Climate Change Mitigation Technologies IN Information AND Communication Technologies [ICT], I.E. Information AND Communication Technologies Aiming AT THE Reduction OF Their OWN Energy USE 7

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 6

Top 15 of 49 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ascensia Diabetes Care Holdings AG's patent record in context - here's where to go next.

Ascensia Diabetes Care Holdings AG's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 62.1% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #1,788 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ascensia Diabetes Care Holdings AG against tesa SE, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 59.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.